Exhibit
10.1


BIOTECH


Research
Group


SCOPE
OF WORK ( SOW) ORDER


	Client	Regen
    Biopharma, Inc.
	SOW
    Number	FWO2-CRO
    Gap Assessment
	SOW
    Effective Date	10/11/2021
	SOW
    Termination Date	11/15/2021
	Master
    Agreement	Master
    Services Agreement dated as of 5/12/2021


 


This
Scope of Work Order ( this “SOW”) is entered into as of the SOW Order Effective Date between BRG and Client.


		1.	Capitalized
                                            Terms: SOW. Capitalized terms used herein and not otherwise defined herein shall have the
                                            meaning set forth in the Master Agreement; this SOW is incorporated by reference into the
                                            Master Agreement; and this SOW is subject to the terms and conditions of the Master Agreement.
                                            Any breach of this SOW shall, for all purposes of the Master Agreement, constitute a breach
                                            of the Master Agreement.



		2.	Services
                                            and Deliverables.

                                            (a) Services. BRG will perform the following Services to and for the benefit of Client pursuant
                                            to this SOW;



	No.	Services
	1.	Conduct
    GAP assessment of CRO IP content on Modulating NR2F6 Checkpoint Pre-Clinical Protocols/Raw Data/ Completion Report.


 


(b)
Deliverables. BRG will deliver and provide to Client the following Deliverables pursuant to this SOW:


	No.	Deliverables
	1.	Deliver
    Gap Assessment Report
	2.	Include
    a work package for regulatory strategy.


 


		3.	Fees
                                            and Expenses Invoicing.

                                            (a) Services will be performed on a time and materials at a fixed fee basis as set forth
                                            below.






	Billing
    Terms	Amount
	Initiation
    of Services

    ( Due immediately after SOW is signed)	$25000
	Intermediate
    Billing of Services

    ( Due midway point)	$0
	Final
    Billing of Services

    (Due before deliverables)	$0
	TOTAL	$25000


(b)
BRG will charge Client for FAERS and other FDA submission fees, if applicable.


(c)
BRG will be entitled to reimbursement of actual out of pocket expenses for travel, food and lodging neccesary for the performance of
the Services , provided that such expenses have been approved, in advance, by Client.


4.
Term and Termination. This SOW shall become effective as of the SOW Order Effective Date and continue in effect until the Scheduled Termination
Date, unless earlier terminated pursuant to the Master Services Agreement or this SOW. This SOW shall be terminable as set forth in the
Master Agreement.


5.
Entire Agreement, Amendment, Waiver. This SOW, together with the Master Agreement and exhibits, schedules and annexes hereto, constitutes
the entire agreement of the parties hereto with resoect to the subject matter hereof, and supersedes all prior and contemporaneous agreements
and understandings, whether written or oral, with respect to the subject matter. The fees for completed work outlined in this SOW will
be payable in full if for any reason outside the control of BRG the services are delayed, cancelled, postponed or otherwise altered.
Including by Client of FDA. Except as set forth in this SOW, the Agreement shall continue in full force and effect in accordance with
its terms and conditions.


IN
WITNESS WHEREOF, the parties have caused this SOW to be duly executed as of the SOW Order Effective Date by the resoective authorized
officers.


	Regen
    Biopharma, Inc.	BRG
	Name:
    David Koos	Name:Christina
    Sanchez Miller, MPH
	Title:
    Chairman and CEO	Titke:
    President/CEO
	Signature:
    /s/David Koos	Signature:
    /s/Christina Sanchez Miller, MPH
	Date:
    10/18/2021	Date:
    10/11/2021